IA · 5 September 2026 · 4 min read
Anthropic's $2 Trillion IPO Puts Its Long-Term Benefit Trust in the Crosshairs
In brief: Anthropic is preparing a historic initial public offering that could value the artificial intelligence company at up to $2 trillion. The planned listing will subject the Claude developer's unconventional corporate governance to intense public-market scrutiny, specifically its Long-Term Benefit Trust: an independent external body with no equity holdings that nevertheless holds the power to select a majority of the board.
by Team Mocchi's
A historic public debut with an experimental safety net
Anthropic’s road toward the public markets is shaping up to be a defining moment for the entire artificial intelligence landscape. With an anticipated valuation that could reach $2 trillion, the creator of the Claude model family is laying the groundwork for a mega-IPO designed to secure computing capital on an unprecedented scale. Yet the transition from venture-backed frontier lab to publicly traded corporate titan will compel Wall Street to navigate an unusual governance framework deliberately engineered to prioritize long-term societal safety over short-term quarterly profits.
As reported by Ars Technica, the spotlight falls squarely on the Long-Term Benefit Trust (LTBT), an independent advisory and oversight body established to keep the company's research trajectory aligned with broad public welfare even as commercial pressures mount. Operating as a Delaware Public Benefit Corporation, Anthropic has granted this trust statutory authorities virtually unheard of in companies of comparable market capitalization.
Inside the Long-Term Benefit Trust
Unlike conventional advisory panels or non-binding ethics boards, the LTBT wields direct legal authority: it possesses the formal power to appoint and dismiss a majority of Anthropic’s board of directors, despite owning zero shares in the firm. To date, four of the company's seven board seats have been filled by trust appointees, including prominent business figures such as Netflix co-founder Reed Hastings and Novartis chief executive Vas Narasimhan.
The trust itself is led by respected figures spanning global health, macroeconomics, and national policy. Chaired by Neil Buddy Shah, chief executive of the Clinton Health Access Initiative, its roster features former Federal Reserve chair Ben Bernanke alongside Center for a New American Security CEO Richard Fontaine. For founders Dario and Daniela Amodei, the LTBT is intended not as a one-off structural quirk, but as an institutional blueprint for the broader frontier AI sector—analogous to how GAAP accounting principles originated as voluntary private standards before becoming market requirements.
In daily operations, the trustees stay closely informed on corporate maneuvers, receiving advance notice of major technology deployments. They hold weekly internal meetings, convene bi-weekly with executive leadership, and participate in full board gatherings. The trust has already exerted quiet influence on pivotal decisions, including shaping the controlled deployment strategy for the Mythos cybersecurity model and steering Anthropic's red lines regarding automated defense contracts.
Wall Street’s expectations versus ethical guardrails
Throughout its private lifecycle, the LTBT has functioned predominantly in a collaborative advisory capacity, avoiding outright standoffs with executive leadership or capital backers. Entering the public markets, however, will introduce a drastically different dynamic. Institutional shareholders and hedge fund managers, bound by fiduciary mandates to maximize financial returns, may chafe at major strategic decisions governed by individuals who bear no direct financial exposure to the stock price.
Public markets have traditionally viewed dual-class shares or non-shareholder governance with skepticism. Anthropic, however, is steadfast in maintaining the trust’s structural authority in its listing documentation, asserting that uncompromising safety governance is precisely what underpins long-term enterprise trust and mitigates systemic risk in an era of rapid algorithmic expansion.
Mocchi's take
For European enterprises and technology agencies leveraging frontier language models, vendor stability and governance integrity are just as critical as raw benchmarks and compute costs. Anthropic’s commitment to preserving its ethical trust through a massive public listing provides valuable assurance that compliance, safety thresholds, and predictable API operations will not be casually sacrificed for short-term financial engineering. Nevertheless, teams engineering mission-critical software systems must keep a close eye on this unprecedented balance, ensuring that internal governance friction does not inadvertently constrain product roadmaps or alter enterprise terms of service.